Through the partnership, Tempus will grant Pfizer access to its data library, diagnostic offerings and clinical trial matching program, according to a Feb. 28 Tempus news release.
“This is the third strategic collaboration Tempus has established with a global pharmaceutical leader in the last year, as we believe that combining our technological capabilities with pharma’s deep research and development expertise will get us much closer in realizing the full potential of precision medicine,” Tempus founder and CEO Eric Lefkofsky said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
